Novavax (NVAX) Misses Q4 EPS by 99c ; Offers Guidance
Tweet
Share
E-mail
Get Alerts NVAX Hot Sheet
Price: $10.80 +1.60%
Financial Fact:
Loss from operations: -63.31M
Today's EPS Names:
OCCI, PMCB, BRID, More
Financial Fact:
Loss from operations: -63.31M
Today's EPS Names:
OCCI, PMCB, BRID, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q4 EPS of ($1.44), $0.99 worse than the analyst estimate of ($0.45). Revenue for the quarter came in at $291 million versus the consensus estimate of $321.97 million.
GUIDANCE:
Novavax sees FY2024 revenue of $0.8-1 billion, versus the consensus of $0.97 billion.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Piper Sandler sees Google TPU sales hitting $104BN by 2028
- AIxCrypto signs non-binding deal to acquire Faraday Future robotics unit
- Timken sells belts business to Gates Industrial
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
